C07C 233/58
Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms
Official title: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C07C233/58 (Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms) appears on 198 US grants and 205 published applications in this corpus.
Search patents in C07C- Granted patents
- 198
- Published applications
- 205
- Assignees
- 140
- Inventors
- 684
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 16 | 0 |
| 1998 | 9 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 5 | 6 |
| 2003 | 4 | 8 |
| 2004 | 2 | 9 |
| 2005 | 2 | 8 |
| 2006 | 5 | 9 |
| 2007 | 9 | 9 |
| 2008 | 3 | 10 |
| 2009 | 7 | 8 |
| 2010 | 7 | 8 |
| 2011 | 10 | 12 |
| 2012 | 9 | 11 |
| 2013 | 13 | 4 |
| 2014 | 3 | 8 |
| 2015 | 6 | 6 |
| 2016 | 3 | 13 |
| 2017 | 3 | 7 |
| 2018 | 8 | 10 |
| 2019 | 5 | 5 |
| 2020 | 6 | 14 |
| 2021 | 10 | 7 |
| 2022 | 8 | 6 |
| 2023 | 6 | 3 |
| 2024 | 3 | 12 |
| 2025 | 6 | 6 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor21 Apr 2026US 12,606,529 B2Research Foundation of the City University of New York
- Compositions and methods for treatment of platinum-based chemotherapeutic resistant tumors7 Apr 2026US 12,595,227 B2The George Washington University
- Compounds advantageous in the treatment of central nervous system diseases and disorders2 Dec 2025US 12,486,218 B2Aurimmed Pharma, Inc.
- Method of therapeutically treating cancer25 Nov 2025US 12,479,813 B2ADT Pharmaceuticals, LLC
- Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof7 Oct 2025US 12,435,051 B2Vivozon Inc.
- Novel flavor compounds9 Jul 2026US 2026/0191244 A1International Flavors & Fragrances Inc.
- Organic compounds and organic light emitting diode comprising the same2 Jul 2026US 2026/0184670 A1Material Science Co., Ltd.
- Novel monomer and chemically recyclable polymer material comprising the same26 Mar 2026US 2026/0085055 A1Korea Institute of Science and Technology
- Modulators of liver receptor homologue 1 (lrh-1) and uses26 Feb 2026US 2026/0055046 A1Emory University
- Cycloalkyl carboxylic acid derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof22 Jan 2026US 2026/0021085 A1Maze Therapeutics, Inc.
Most cited
By later US patents
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents86US 7,071,355 B24 Sc AG · 2006
- Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity80US 5,489,584 AAllergan, Inc. · 1996
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity76US 5,543,534 AAllergan, Inc. · 1996
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity70US 5,514,825 AAllergan, Inc. · 1996